FN Archimer Export Format PT J TI Effect of an oversulfated exopolysaccharide on angiogenesis induced by fibroblast growth factor-2 or vascular endothelial growth factor in vitro BT AF MATOU, Sabine COLLIEC-JOUAULT, Sylvia GALY FAUROUX, Isabelle RATISKOL, Jacqueline SINQUIN, Corinne GUEZENNEC, Jean FISCHER, Anne-Marie HELLEY, Dominique AS 1:;2:;3:;4:;5:;6:;7:;8:; FF 1:PDG-DOP-DCB-BM-BMM;2:PDG-DOP-DCB-BM-BMM;3:;4:PDG-DOP-DCB-BM-BMM;5:PDG-DOP-DCB-BM-BMM;6:PDG-DOP-DCB-BM-BMM;7:;8:; C1 Univ Paris 05, INSERM, F-75006 Paris, France. IFREMER, Nantes, France. Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Paris, France. C2 UNIV PARIS 05, FRANCE IFREMER, FRANCE HOP EUROPEEN GEORGES POMPIDOU, FRANCE SI BREST NANTES SE PDG-DOP-DCB-BM-BMM IN WOS Ifremer jusqu'en 2018 copubli-univ-france IF 3.617 TC 37 UR https://archimer.ifremer.fr/doc/2005/publication-2118.pdf LA English DT Article DE ;Matrigel;Collagen gel;Alpha 6 integrin subunit;Angiogenic growth factor;Polysaccharide;Angiogenesis AB The aim of this study was to determine the angiogenic properties of an oversulfated exopolysaccharide (OS-EPS) derived from a polysaccharide secreted by the mesophilic bacterium Alteromonas infernus. We compared the effect of this OS-EPS with that of a non-oversulfated exopolysaccharide (EPS) on human umbilical vein endothelial cell (HUVEC) proliferation, migration and differentiation induced by basic fibroblast growth factor (FGF-2) or vascular endothelial growth factor (VEGF). OS-EPS enhanced HUVEC proliferation by 58% when used alone, and by respectively 30% and 70% in the presence of FGF-2 and VEGF. OS-EPS also increased the density of tubular structures on Matrigel in the presence of FGF-2 or VEGF. Vascular tube fort-nation was related to alpha(6) integrin subunit expression, which was enhanced by 50% in the presence of the growth factors. Indeed, a monoclonal anti-alpha(6) blocking antibody abolished this vascular tube formation. EPS had no effect in any of the experimental conditions, underlying the importance of sulfation in the angiogenic effects of exopolysaccharide. By potentiating the angiogenic activity of FGF-2 and/or VEGF, OS-EPS, which possesses low anticoagulant activity and thus a low hemorrhagic risk, could potentially be used to accelerate vascular wound healing or to promote the growth of collateral blood vessels in ischemic tissues. (C) 2004 Elsevier Inc. All rights reserved. PY 2005 PD MAR SO Biochemical Pharmacology SN 0006-2952 PU Elsevier VL 69 IS 5 UT 000227371400005 BP 751 EP 759 DI 10.1016/j.bcp.2004.11.021 ID 2118 ER EF